Evaluation of Fractional Exhaled Nitric Oxide During SARS-CoV-2 Infection

J Investig Allergol Clin Immunol. 2022 Jul 22;32(4):301-303. doi: 10.18176/jiaci.0762. Epub 2021 Nov 10.

Authors

D Betancor¹, M Valverde-Mongue¹, A Gomez-Lopez¹, B Barroso¹, L Ruete², J M Olaguibel^{3

4}, J Sastre^{1

4}

Affiliations

¹ Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
² Eversens, Pamplona, Navarra, Spain.
³ Allergy Department, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain.
⁴ CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

PMID: 34755657
DOI: 10.18176/jiaci.0762

No abstract available

Keywords: COVID-19; Exhaled nitric oxide; SARS-CoV-2.

MeSH terms

Breath Tests
COVID-19*
Exhalation
Fractional Exhaled Nitric Oxide Testing*
Humans
Nitric Oxide
SARS-CoV-2

Substances

Nitric Oxide